#ASCO14 - Poster: Patient-reported quality of life analysis of radium-223 dichloride evaluating pain relief from the phase 3 ALSYMPCA study

CHICAGO, IL USA (UroToday.com) - Presented by Sten Nilsson,¹ Michael Tomblyn,² Paul Cislo,³ Jonathan Reuning-Scherer,⁴ and Christopher Parker⁵ at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

¹Karolinska University Hospital, Stockholm, Sweden
²Algeta US (Bayer), Cambridge, MA, USA
³Bayer HealthCare, Whippany, NJ, USA
⁴Yale University, New Haven, CT, USA
⁵The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK